BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2408948)

  • 1. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL; Weir GC
    Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal regulation by glucose of somatostatin secretion in the perfused pancreas of NIDDM rats.
    Ostenson CG; Efendic S; Grill V
    Pancreas; 1990 May; 5(3):347-53. PubMed ID: 1971441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
    Grill V; Rundfeldt M
    Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium ion concentration alters glucagon secretion independently of insulin secretion in the isolated rat pancreas.
    Smith SS; Bhathena SJ; Wilkins SD; Recant L
    Diabetologia; 1982 Mar; 22(3):188-93. PubMed ID: 7042431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective impairment of pancreatic A cell suppression by glucose during acute alloxan-induced insulinopenia: in vitro study on isolated perfused rat pancreas.
    Filipponi P; Gregorio F; Cristallini S; Ferrandina C; Nicoletti I; Santeusanio F
    Endocrinology; 1986 Jul; 119(1):408-15. PubMed ID: 3522213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased beta-cell secretory responsiveness to ceruletide and TPA in streptozocin-induced mildly diabetic rats.
    Okabayashi Y; Otsuki M; Ohki A; Tani S; Baba S
    Diabetes; 1989 Aug; 38(8):1042-7. PubMed ID: 2526762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreas.
    Ostenson CG; Ahrén B; Karlsson S; Sandberg E; Efendic S
    Regul Pept; 1990 Jul; 29(2-3):143-51. PubMed ID: 1699250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
    Honey RN; Schwarz JA; Mathe CJ; Weir GC
    Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model.
    Tsuji K; Taminato T; Usami M; Ishida H; Kitano N; Fukumoto H; Koh G; Kurose T; Yamada Y; Yano H
    Metabolism; 1988 Nov; 37(11):1040-4. PubMed ID: 3054430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas.
    Giroix MH; Portha B; Kergoat M; Bailbe D; Picon L
    Diabetes; 1983 May; 32(5):445-51. PubMed ID: 6341128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose- and arginine-induced insulin and glucagon responses from the isolated perfused pancreas of the BB-Wistar diabetic rat. Evidence for selective impairment of glucose regulation.
    Grill V; Herberg L
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):561-6. PubMed ID: 6342326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats.
    Pederson RA; Ramanadham S; Buchan AM; McNeill JH
    Diabetes; 1989 Nov; 38(11):1390-5. PubMed ID: 2695373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin.
    Kergoat M; Bailbe D; Portha B
    Diabetes; 1987 Aug; 36(8):971-7. PubMed ID: 3297892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.